Sai Reddy

Founder at

Engimmune Therapeutics AG

Consumer Services

Finance

Commercial Services

Profile

Sai Reddy is the founder of Engimmune Therapeutics AG, founded in 2021, holding the title of Director since 2021.
Dr. Reddy currently holds the positions of Chairman at deepCDR Biologics AG and Venture Partner at Pureos Partners AG.
Dr. Reddy completed a doctorate degree at École Polytechnique Fédérale de Lausanne in 2008 and an undergraduate degree at Northwestern University in 2003.

Sai Reddy active positions

Companies	Position	Start
deepCDR Biologics AG deepCDR Biologics AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Chairman	-
Engimmune Therapeutics AG Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers	Founder	2020-12-31
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Private Equity Investor	-

All active positions of Sai Reddy

Training of Sai Reddy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sai Reddy's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
École Polytechnique Fédérale de Lausanne École Polytechnique Fédérale de Lausanne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Finance
deepCDR Biologics AG deepCDR Biologics AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Commercial Services
Engimmune Therapeutics AG Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers	Health Technology

See company connections